• GSK adjusts FY2018 guidance after encouraging Q2 results pharmaceutical-technology
    July 30, 2018
    GlaxoSmithKline (GSK) has upgraded its full year (FY) 2018 guidance after recording growth in sales, margins and cash flow in its financial report for the second quarter (Q2) of 2018.
PharmaSources Customer Service